Dr Agarwal's Eye
DRAGARWQ • Healthcare Services
Last Price
₹5163.00
Market Cap
₹2.50K Cr
Sector
Healthcare Services
For educational/research use only. Not a recommendation to buy or sell.
At a glance
as of 2026-10-15Sector: Dr Agarwal's Eye (DRAGARWQ) is an NSE-listed company in the Healthcare Services sector, within the Hospital industry. NSE sector rotation chart
Sharia rating: Dr Agarwal's Eye is rated Halal by a specialist third-party provider. Full list of halal NSE stocks
Price trend
No reading
We don't have enough data to measure this for Dr Agarwal's Eye right now.
Institutional activity
Neutral
Trading patterns over recent weeks show no clear sign of institutions buying or selling Dr Agarwal's Eye (buying score 2/10, selling score 1/10).
Model rank
Positive
Our model's 5-day return score puts Dr Agarwal's Eye ahead of 72% of NSE stocks. The model has low confidence in this score (43%).
Ease of trading
Low
Shares change hands easily; there are no signs of trading drying up (risk score 2/10).
Price vs profits
Above typical
The share price is 36× last year's profit per share — above the typical range for NSE stocks (15–30×).
The wider Indian market is in a crisis regime — unusually sharp moves (model 100% sure). This affects every stock's model rank.
Browse ready-made screens →Company Information
About Dr Agarwal's Eye (DRAGARWQ)
Dr Agarwal's Eye is an NSE-listed company operating in the Healthcare Services sector, within the Hospital industry (ISIN INE934C01018). This page brings together the quantitative research signals our models compute for DRAGARWQ: a model-estimated 1-day, 5-day and 21-day return outlook, momentum and trend indicators, institutional-activity context derived from observed trading flows, a snapshot of valuation and quality fundamentals, and the instrument's Sharia-compliance status. All figures are produced by statistical models from historical data and are intended for research and educational purposes.
To read the page, treat the model-estimated return outlook as a relative ranking signal rather than a forecast of price — higher scores reflect stronger model-estimated momentum and trend alignment, not a target or guarantee. The momentum and trend indicators describe how Dr Agarwal's Eye's recent price action compares with its own history, while the fundamentals and institutional-activity context add longer-horizon and flow-based perspective. Nothing here is investment advice, a recommendation, or a solicitation to transact; always do your own research and consult a SEBI-registered adviser before making any decision.
The "typical range" we compare a price-to-earnings multiple against is a fixed band for all NSE stocks, not a sector-specific one. Everything on this page describes what our models measured; none of it is a recommendation to do anything.